Large OEMs and materials companies
STERIS agreed to buy Xodus Medical. STERIS signed a definitive agreement on Oct. 11 and announced it Oct. 12 to acquire Xodus Medical, the Pittsburgh-area maker of Pink Pad patient positioning products, for $2.1 billion at closing (about $1.8 billion net of expected cash tax benefits), plus an earnout of up to $150 million tied to 2028 targets. STERIS expects to close by Dec. 31, 2026. CEO Dan Carestio framed the deal around "adding consumables used in the operating room." (STERIS, MedTech Dive)
Why it matters: foams, gels, films and nonwovens for positioning products now sit inside a larger buyer. Suppliers to Xodus can expect the usual post-close review of approved supplier lists, quality agreements and contract terms.
GE HealthCare agreed to buy SOFIE Biosciences. GE HealthCare plans to acquire SOFIE, a U.S. contract manufacturer of PET radiopharmaceuticals with 15 CMO sites and 21 cyclotrons, for $945 million in cash, with closing expected in the first half of 2027. Both companies said SOFIE will keep operating as an independent manufacturing partner to its existing customers, including for products from other radiopharmaceutical companies. (SOFIE)
Why it matters: this is an OEM bringing a contract manufacturer in-house while promising to keep serving outside customers. Teams that rely on a CMO bought by a larger company should get the continuity commitment in writing in their supply agreement, not only in a press release.
Medtronic completed the MiniMed separation. Medtronic finished separating its diabetes business into MiniMed Group, Inc. on Oct. 15. (Medtronic)
Why it matters: suppliers of pump, sensor and infusion set components now have a separate company as their counterparty. Purchase orders, quality agreements and supplier portals may move to new entities on their own schedule, so check which legal entity each agreement names.
Boston Scientific lowered its outlook after a cybersecurity incident. In its Oct. 28 third-quarter release, Boston Scientific reported net sales of $5.138 billion, up 1.5%, and lowered full-year growth guidance to about 4.25% reported. It expects fourth-quarter sales to decline about 1% to 3%. CEO Mike Mahoney cited the cybersecurity incident the company first disclosed in August and said teams were working "to restore operations." (Boston Scientific via PR Newswire, MedTech Dive)
Why it matters: an outage at a large customer reaches its suppliers through order timing, EDI and portal access. The incident is a reminder to keep a manual fallback for purchase orders and shipping documents with every key customer.
Bracco plans its first U.S. contrast media plant. Bracco announced a $230 million sterile manufacturing facility for injectable contrast media in Sanford, North Carolina, expected to bring about 200 jobs and complement its production in Europe, Asia and Canada. Fulvio Renoldi Bracco said the plant "brings our supply closer to American hospitals and patients and makes it even more resilient." (Bracco via PR Newswire)
Why it matters: a new U.S. sterile fill operation needs vials, stoppers, syringes and packaging qualified close to the site. Suppliers of those components in the Southeast have a new potential customer at the qualification stage.
Natus opened a development and manufacturing site in Suzhou. Natus celebrated the opening of its Suzhou facility on Oct. 27. Its Nicolet EDX EMG system, built there, became the first Natus product manufactured and registered in China, with NMPA approval on June 18. The company noted that hospital procurement in China "increasingly prioritizes locally manufactured medical technologies." (Natus via PR Newswire)
Why it matters: building in China for China usually means qualifying local sources for electronics, cables and enclosures. Suppliers to a company making that move should ask early which components will be dual-sourced and which will stay global.
Medtronic recalls traced to manufacturing and material variation. Medtronic recalled more than 700 non-implanted OmniaSecure defibrillation leads in a Class II action. A spokesperson said the issue is "limited to a subset of leads that may have undergone a specific manufacturing sequence as identified by an internal quality process" and that there have been no reports of patient harm. Separately, FDA's Oct. 16 enforcement report listed a Class II recall of NDI passive spheres and biopsy needle kits for "variation in reflective material which may affect the ability of the navigation system to detect and track the spheres." (Cardiovascular Business, Recall Canary summary of the FDA notice)
Why it matters: both recalls come down to variation in a process sequence or a purchased material. Lot traceability on coatings and films, plus clear records of the process route each lot took, are what make a recall this narrow possible.
DuPont named its Tyvek sustainable packaging award winners. On Oct. 5, DuPont announced three winners: a recycled-polyester tub and lid paired with Tyvek, a suture package that drops an entire outer layer by using an aluminum pouch with a Tyvek strip, and an all-polyethylene header bag laminate certified as recyclable. (DuPont)
Why it matters: the suture example shows a way to cut material and sterilization cost by removing a layer while keeping the sterile barrier. Any change like that still means repeating package validation, so it pays to plan it alongside a scheduled design change.
Regulation and standards
New Mexico is reconsidering its fluoropolymer exemption. The New Mexico Environment Department held a public meeting on Oct. 8 about whether exemptions in the state's PFAS Protection Act, including the one for fluoropolymers, should continue. A legislative memorial passed in February directs the department to report by Aug. 1, 2027. Interim findings go to a legislative committee on Nov. 5, and public comments are open through Dec. 31, 2026. Medical devices are a separate exempt category under the act. (Verdant Law)
Why it matters: fluoropolymer resin and film suppliers sell into many markets beyond medical, so a change to the materials exemption could affect supply even while the device exemption stays in place. Anyone with PTFE, FEP or ETFE in a bill of materials has until year-end to comment.
EPA launched a PFAS treatment technology strategy. On Oct. 26, EPA announced its agency-wide PFAS TECH strategy, covering funding and pilot projects for PFAS treatment and destruction, a planned "Break the Bond Navigator" database for utilities, and work with about 40 utilities. (ASDWA, EPA strategy PDF)
Why it matters: the strategy is about cleanup and water treatment, not restrictions on materials in products. For device makers it is mainly relevant to plants that discharge fluorinated process waste.
The 2024 ethylene oxide rule still applies while EPA's rollback is pending. EPA proposed rolling back parts of its 2024 sterilizer emissions rule in March, and the comment period closed May 15. As of October, a final rule had not been issued, so the 2024 standards remain in effect, and state rules such as Illinois's 99.9% control requirement apply regardless. (Faegre Drinker, EPA)
Why it matters: sterilization capacity and pricing still depend on the 2024 compliance work at each site. Teams whose products go through a single EO site should keep a second validated option on their list.
FDA revised its draft guidance on drug delivery performance. FDA published a revised draft of "Essential Drug Delivery Performance Characteristics for Devices Intended to Deliver Drugs and Biological Products" on Oct. 30, aligned with the revised Quality Management System Regulation. Comments are due Jan. 28, 2027. (Federal Register, FDA draft guidance PDF)
Why it matters: dose accuracy, delivery time and similar characteristics trace back to springs, plungers, needles and fluid-path parts. Suppliers of those parts should expect customers to ask for tighter characterization data on the features that drive them.
Research heading toward production
BARDA funded a portable X-ray through design transfer. OXOS Medical announced on Oct. 6 a BARDA cost-share contract with a $9.6 million base and up to $24.4 million if all options are exercised, matched by OXOS. The scope runs from development and verification through design transfer to manufacturing, FDA submission and first commercial shipments of the X3, which is not yet cleared. (OXOS via PR Newswire)
Why it matters: a government-funded program with design transfer in scope will be choosing production suppliers for enclosures, detectors and batteries within the contract period.
Notre Dame reported a low-cost catheter coating. Researchers led by microbiologist Ana Flores-Mireles developed a silicone-based coating for urinary catheters that reduced the buildup that lets infections take hold in preclinical studies. She estimates it would add about $1 to the cost of an existing catheter. The team sees possible uses in central lines, dialysis catheters and other devices, and says more study is needed before it reaches patients. (University of Notre Dame via PR Newswire)
Why it matters: a coating priced at that level is meant for high-volume commodity catheters, which puts coating line throughput and cure time at the center of any scale-up.
Supplier and CDMO moves
Meiban completed its acquisition of Planet Innovation. Meiban, a Singapore-based contract manufacturer with seven sites in Singapore and Malaysia, now owns all of Planet Innovation, the product development company in Melbourne and Irvine, after taking a roughly 20% stake in 2025. Planet Innovation keeps its brand and leadership. (Planet Innovation)
Why it matters: development and high-volume manufacturing now sit under one owner. Clients of either company should confirm whether their design files, tooling ownership and transfer terms change.
Surmodics acquired Alta Biomed's PzF surface technology. Surmodics bought the business of Alta Biomed, a coating and testing services company, adding its PzF ultra-thin polymer surface modification for blood- and tissue-contacting devices. PzF can be applied to metals, polymers, fabrics and tissue, including nitinol, ePTFE and PET. (Vascular News))
Why it matters: existing PzF users have a new owner for their coating supply and testing records, and should confirm that process specifications and change-notification terms carry over.
Currier Plastics became Alentra. Currier, the Auburn, New York, molder, renamed itself Alentra on Oct. 15 as it offers design and development alongside component manufacturing and finished device assembly. It acquired Springboard Manufacturing and MOS Plastics in December 2025 and Sage Product Development in August 2026. (Alentra)
Why it matters: a name change shows up on certificates, labels and approved supplier lists. Customers will need updated ISO certificates and supplier records under the new name.
Several of these stories are still in motion. The STERIS and GE HealthCare deals haven't closed, the New Mexico comment period runs to year-end, and EPA's final ethylene oxide rule is still pending. Next month's roundup will pick up where each one lands.
Sources
- STERIS, "STERIS Expands Healthcare Consumables Offering," Oct. 12, 2026: https://sterisplc.gcs-web.com/news-releases/news-release-details/steris-expands-healthcare-consumables-offering-definitive/
- MedTech Dive, STERIS–Xodus coverage: https://www.medtechdive.com/news/steris-inks-21b-xodus-buyout-to-expand-consumables-portfolio/832822/
- SOFIE / GE HealthCare release, Oct. 5, 2026: https://sofie.com/2026/10/05/ge-healthcare-to-acquire-sofie-biosciences-establishing-a-final-mile-footprint-for-pet-radiopharmaceutical-supply-in-the-u-s/
- Medtronic, MiniMed separation, Oct. 15, 2026: https://news.medtronic.com/2026-10-15-Medtronic-Completes-Separation-of-MiniMed-Group,-Inc
- Boston Scientific Q3 2026 results, Oct. 28, 2026: https://www.prnewswire.com/news-releases/boston-scientific-announces-results-for-third-quarter-2026-302921450.html
- MedTech Dive, Boston Scientific guidance: https://www.medtechdive.com/news/boston-scientific-cuts-2026-guidance-for-third-time-this-year/873037/
- Bracco, Sanford plant, Oct. 27, 2026: https://www.prnewswire.com/news-releases/bracco-announces-230-million-investment-in-first-us-manufacturing-facility-for-injectable-contrast-media-302921221.html
- Natus, Suzhou facility, Oct. 27, 2026: https://www.prnewswire.com/news-releases/natus-celebrates-grand-opening-of-suzhou-facility--advancing-innovation-in-china-for-china-302919085.html
- Cardiovascular Business, OmniaSecure lead recall, Oct. 26, 2026: https://cardiovascularbusiness.com/topics/clinical/heart-rhythm/medtronic-recalls-defibrillation-leads-due-risk-implant-issues
- Recall Canary, NDI passive spheres (FDA enforcement report, Oct. 16, 2026): https://recallcanary.com/recall/fda/medtronic-ndi-passive-spheres
- DuPont, Tyvek Sustainable Healthcare Packaging Awards, Oct. 5, 2026: https://www.dupont.com/news/dupont-announces-winners-of-third-annual-tyvek-sustainable-healthcare-packaging-awards.html
- Verdant Law, "NMED Seeks Public Input on New Mexico's PFAS Exemptions," Oct. 14, 2026: https://www.verdantlaw.com/nmed-seeks-public-input-on-new-mexicos-pfas-exemptions/
- ASDWA, "EPA Launches PFAS Technology Strategy," Oct. 26, 2026: https://www.asdwa.org/2026/10/26/epa-launches-pfas-technology-strategy/
- EPA, PFAS TECH strategy: https://www.epa.gov/system/files/documents/2026-10/pfas-tech-strategy_final.pdf
- Faegre Drinker, "Ethylene Oxide Regulations in Transition," Oct. 2026: https://www.faegredrinkeronproducts.com/2026/10/ethylene-oxide-regulations-in-transition-what-you-need-to-know/
- EPA, ethylene oxide sterilizer standards: https://www.epa.gov/stationary-sources-air-pollution/ethylene-oxide-emissions-standards-sterilization-facilities
- Federal Register, drug delivery performance draft guidance, Oct. 30, 2026: https://www.federalregister.gov/documents/2026/10/30/2026-22203/essential-drug-delivery-performance-characteristics-for-devices-intended-to-deliver-drugs-and
- FDA, draft guidance PDF: https://www.fda.gov/media/179545/download
- OXOS Medical, BARDA contract, Oct. 6, 2026: https://www.prnewswire.com/news-releases/oxos-medical-awarded-barda-contract-worth-up-to-24-million-to-develop-x3-ultra-portable-x-ray-imaging-system-302898929.html
- University of Notre Dame, catheter coating, Oct. 27, 2026: https://www.prnewswire.com/news-releases/notre-dame-researchers-develop-low-cost-approach-to-preventing-catheter-infections-302917134.html
- Planet Innovation, Meiban acquisition, Oct. 2026: https://planetinnovation.com/perspectives/planet-innovation-and-meiban-join-forces/
- Vascular News, Surmodics and Alta Biomed, Oct. 7, 2026: https://vascularnews.com/surmodics-adds-ultra-thin-polymer-surface-modification-technology-to-its-haemocompatible-portfolio/
- Alentra, Currier rebrand, Oct. 15, 2026: https://alentracdmo.com/news-and-events/currier-rebrands-as-alentra-a-full-servicehealthcare-life-sciences-cdmo/
This article is put together on a best-effort basis from publicly available information, including company websites, press releases, and trade publications, as of the date of publication. Specifications, certifications, products, and company details can change, so confirm anything important directly with the supplier. Opinions are the author’s own. Mentions of a company, product, or marketplace are not endorsements or sponsorships, and nothing here is professional, engineering, regulatory, or purchasing advice.